Thomas Tursz

Immunology and Microbiology · Life Sciences

69h-index25.8kcitations272works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(73), Viral-associated cancers and disorders(39), Immunotherapy and Immune Responses(38), Lymphoma Diagnosis and Treatment(32), T-cell and B-cell Immunology(31)

Publications271 total

La nouvelle immunothérapie des cancers :éle réveil de la Belle au Bois Dormant ?
2017
Excellent translational research in oncology: A journey towards novel and more effective anti‐cancer therapies
Molecular Oncology·2015· 12 citedOpen Access
[Not Available].
PubMed·2014
Courage, Conviction et Persévérance
Bulletin de l Académie Nationale de Médecine·2014
Pioneering Quality Assessment in European Cancer Centers: A Data Analysis of the Organization for European Cancer Institutes Accreditation and Designation Program
Journal of Oncology Practice·2014· 32 citedOpen Access
Hurdles on the road to personalized medicine
Molecular Oncology·2014· 15 citedOpen Access
Personalized treatments of cancer patients: A reality in daily practice, a costly dream or a shared vision of the future from the oncology community?
Cancer Treatment Reviews·2014· 70 cited
A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences
Molecular Oncology·2013· 43 citedOpen Access
Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes
The Breast·2013· 49 citedOpen Access
Abstract P4-09-05: Microarray anlyses of breast cancers identify CH25H, a cholesterol gene, as a potential marker and target for late metastatic reccurences.
Cancer Research·2012· 1 cited
92 Personalised Oncology – a Worldwide Challenge for Drug Development, Epidemiology, and Public Health
European Journal of Cancer·2012Open Access
WIN Consortium—challenges and advances
Nature Reviews Clinical Oncology·2011· 16 cited
Implications of personalized medicine—perspective from a cancer center
Nature Reviews Clinical Oncology·2011· 62 cited
Updated Technology to Produce Highly Immunogenic Dendritic Cell-derived Exosomes of Clinical Grade
Journal of Immunotherapy·2010· 192 cited
Intensive Induction Chemotherapy without Methotrexate in Adult Patients with Localized Osteosarcoma: Results of the Institut Gustave-Roussy Phase II Trial
Current Oncology·2010· 30 citedOpen Access
Development of a multi-centric assessment tool for measuring and improving standardised organisation and provision of care in cancer structures
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)·2010
L'annonce de la maladie : satisfaction des patients et démarche qualité dans les Centres de lutte contre le cancer
Bulletin du Cancer·2010· 9 cited
Hommage à Yves Cachin (1916-2010)
Bulletin du Cancer·2010
Imatinib Mesylate (Gleevec©): Targeted Therapy Against Cancer with Immune Properties
Endocrine Metabolic & Immune Disorders - Drug Targets·2010· 5 cited
Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?
Cancer Research·2010· 326 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Laurence Zitvogel(16), Fabrice André(9), Caroline Flament(9), Nathalie Chaput(9), Pierre Busson(9), Bernard Escudier(8), Eric Angevin(7), Joëlle Wiels(6), Sebastián Amigorena(5), Julien Taı̈eb(5), Hiro Wakasugi(5), Marta M. Lipinski(5), François Ghiringhelli(4), Graça Raposo(4), Sophie Novault(4), Caroline Robert(4), Magali Terme(4), Jacky Bernard(4), Gilbert Lenoir(4), Nancy Raab‐Traub(4)